209 related articles for article (PubMed ID: 37047289)
1. Next Generation of Ovarian Cancer Detection Using Aptamers.
Abreu RDS; Antunes D; Moreira ADS; Passetti F; Mendonça JB; de Araújo NS; Sassaro TF; Alberto AVP; Carrossini N; Fernandes PV; Costa MA; Guimarães ACR; Degrave WMS; Waghabi MC
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047289
[TBL] [Abstract][Full Text] [Related]
2. Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX.
Van Simaeys D; López-Colón D; Sefah K; Sutphen R; Jimenez E; Tan W
PLoS One; 2010 Nov; 5(11):e13770. PubMed ID: 21072169
[TBL] [Abstract][Full Text] [Related]
3. In vitro selection of DNA aptamers recognizing drug-resistant ovarian cancer by cell-SELEX.
He J; Wang J; Zhang N; Shen L; Wang L; Xiao X; Wang Y; Bing T; Liu X; Li S; Shangguan D
Talanta; 2019 Mar; 194():437-445. PubMed ID: 30609555
[TBL] [Abstract][Full Text] [Related]
4. Identification of epithelial ovarian tumor-specific aptamers.
Benedetto G; Hamp TJ; Wesselman PJ; Richardson C
Nucleic Acid Ther; 2015 Jun; 25(3):162-72. PubMed ID: 25894736
[TBL] [Abstract][Full Text] [Related]
5. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.
Fang X; Tan W
Acc Chem Res; 2010 Jan; 43(1):48-57. PubMed ID: 19751057
[TBL] [Abstract][Full Text] [Related]
6. Identification of liver cancer-specific aptamers using whole live cells.
Shangguan D; Meng L; Cao ZC; Xiao Z; Fang X; Li Y; Cardona D; Witek RP; Liu C; Tan W
Anal Chem; 2008 Feb; 80(3):721-8. PubMed ID: 18177018
[TBL] [Abstract][Full Text] [Related]
7. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in cell-SELEX technology for aptamer selection.
Kaur H
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2323-2329. PubMed ID: 30059712
[TBL] [Abstract][Full Text] [Related]
9. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
10. Current approaches in SELEX: An update to aptamer selection technology.
Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
[TBL] [Abstract][Full Text] [Related]
11. Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy.
Mahlknecht G; Sela M; Yarden Y
Methods Mol Biol; 2015; 1317():3-15. PubMed ID: 26072398
[TBL] [Abstract][Full Text] [Related]
12. Aptamers: new arrows to target dendritic cells.
Ganji A; Varasteh A; Sankian M
J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
[TBL] [Abstract][Full Text] [Related]
13. Selection of DNA aptamers for ovarian cancer biomarker HE4 using CE-SELEX and high-throughput sequencing.
Eaton RM; Shallcross JA; Mael LE; Mears KS; Minkoff L; Scoville DJ; Whelan RJ
Anal Bioanal Chem; 2015 Sep; 407(23):6965-73. PubMed ID: 25863801
[TBL] [Abstract][Full Text] [Related]
14. Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer.
Costello AM; Elizondo-Riojas MA; Li X; Volk DE; Pillai AK; Wang H
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770931
[TBL] [Abstract][Full Text] [Related]
15. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
16. Systematic evaluation of cell-SELEX enriched aptamers binding to breast cancer cells.
Civit L; Taghdisi SM; Jonczyk A; Haßel SK; Gröber C; Blank M; Stunden HJ; Beyer M; Schultze J; Latz E; Mayer G
Biochimie; 2018 Feb; 145():53-62. PubMed ID: 29054799
[TBL] [Abstract][Full Text] [Related]
17. Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated via Cell-SELEX.
Xu J; Teng IT; Zhang L; Delgado S; Champanhac C; Cansiz S; Wu C; Shan H; Tan W
PLoS One; 2015; 10(5):e0125863. PubMed ID: 25938802
[TBL] [Abstract][Full Text] [Related]
18. From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors.
Cibiel A; Quang NN; Gombert K; Thézé B; Garofalakis A; Ducongé F
PLoS One; 2014; 9(1):e87002. PubMed ID: 24489826
[TBL] [Abstract][Full Text] [Related]
19. Production of aptamers by cell-SELEX and their applications in cancer biomarker identification.
Zhao J; He J; Zhong L; Huang Y; Zhao Y
Discov Med; 2020; 29(158):159-167. PubMed ID: 33007191
[TBL] [Abstract][Full Text] [Related]
20. [Efficient screening for 8-oxoguanine DNA glycosylase binding aptamers via capillary electrophoresis].
Han S; Zhao L; Yang G; Qu F
Se Pu; 2021 Jul; 39(7):721-729. PubMed ID: 34227370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
